P4P programs aim to track, prevent growing MRSA epidemic
July 1st 2008Methicillin-resistant Staphylococcus aureus (MRSA), a type of bacterium that is resistant to certain antibiotics, has become a national epidemic, with increasing numbers of serious infections, hospitalizations and deaths. Hospital stays for these infections tripled from 2000 to 2005.
Read More
Grassroots movement grants medical home, access to uninsured
July 1st 2008While legislators and healthcare stakeholders across the country wrangle over the problem of the nation's 46.5 million uninsured, a grassroots movement called Project Access is having an impact on the health of thousands of uninsured Americans.
Read More
Wacky ad campaign reaches the right people
July 1st 2008Your advertising campaign has officially become old-school. That stock image of pleasant patients and attractive doctors? You aren't catching anyone's attention with that approach anymore. Meet HealthPartners' new mascot: Petey P. Cup. Yes, that's right, a urine specimen cup is a walking, dancing, huggable mascot that makes appearances at clinics, health fairs and events around the Twin Cities. Petey also has a syringe sidekick named Pokey.
Read More
Genetic precision: New fields in genetic testing lend support to clinical effectiveness
July 1st 2008Genetic testing is used to predict or diagnose a disease for an individual. It also makes possible the use of pharmacogenetics-the study of genetic variation that translates to differing response to drugs-to align drug treatment for maximum effectiveness. The emerging field of pharmacogenetics has opened up a new world of personalized treatment and evidence-based medicine.
Read More
Purchasing value: The Pacific Business Group on Health champions nationwide innovation
July 1st 2008When Peter Lee stepped down in January from his eight-year tenure as president and CEO of the Pacific Business Group on Health (PBGH), he chose to stay close to home, taking over the new role of executive director of national health policy for this non-profit organization of large employers and other major purchasers. Although Lee wears a new hat, he is confident that he has left the CEO position in the hands of a competent and experienced healthcare thought leader: David Lansky. The duo has easily blended its expertise-Lansky as the information technology whiz and Lee as the national healthcare policy guru and patient advocate. Both share a passion for data and measurement.
Read More
States decide business of insurance
July 1st 2008Capitation and other risk-sharing arrangements have been pursued by provider organizations for the past two decades. Yet the law on whether such arrangements result in the provider organization being in the business of insurance has not fully evolved in all states.
Read More
Maintain competitive cost structure in uncertain economic times
July 1st 2008Regardless of an insurer's composition - public or private, large or small, geographically diverse or regionally focused - reducing non-labor general and administrative (G&A) expenses can contribute greatly to margin improvement.
Read More
CDC urges flu vaccination for all children
July 1st 2008The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted to expand the recommended ages for annual influenza vaccination to include all children from 6 months through 18 years of age.
Read More
Maintain confidentiality with ERISA plans
July 1st 2008The purpose of the attorney-client privilege is to encourage frank communications between attorneys and clients, which promotes dissemination of sound legal advice. Regarding the Employee Retirement Income Security Act of 1974, as amended ("ERISA"), some courts have found that an ERISA plan fiduciary may not assert the attorney-client privilege against plan participants regarding matters of plan administration.
Read More
Dual receptor antagonist demonstrated to be effective in reducing SBP
June 30th 2008An investigational first-in-class dual angiotensin and endothelin receptor antagonist lowered systolic blood pressure (SBP) in patients with stage 1 and 2 hypertension in a phase 2a trial, reported Joel M. Neutel, MD, associate professor of medicine, University of California, Irvine, and medical director of clinical pharmacology, Orange County Research Center, Tustin, California. These results were presented at the 23rd Annual Scientific Meeting of the American Society of Hypertension, New Orleans, May 14–17, 2008.
Read More
Amlodipine plus olmesartan superior to monotherapy in difficult-to-treat hypertensive populations
June 30th 2008The combination of amlodipine and olmesartan was demonstrated to be superior to monotherapy with either agent in difficult-to-treat hypertensive populations in a subgroup analysis of the registrational trial for this combination therapy. These results were presented at the 23rd Annual Scientific Meeting of the American Society of Hypertension, New Orleans, May 14–17, 2008.
Read More
More employers using incentives
June 30th 2008The number of major employers offering employee wellness programs with incentives grew over the past year, according to a study presented by Health2 Resources. The National Association of Manufacturers and The ERISA Industry Committee participated in the survey.
Read More
Lack of access can be life-changing
June 30th 2008Access to coverage, especially for individuals and small groups, is a constant issue. So much so that many Americans are taking great steps to change their lifestyles in order to obtain it. Get married to gain access to insurance? Some are doing just that.
Read More
Government proposal could allow e-Rx of controlled substances
June 30th 2008U.S. drug regulators are said to be close to allowing doctors to e-prescribe addictive medications, including painkillers. According to Reuters, the Drug Enforcement Administration is expected to publish a proposal on e-prescribing controlled substances.
Read More
Two votes determine Medicare payment rule
June 30th 2008Two votes from Republican senators killed a House bill that would have averted statutory payment reductions for Medicare physicians, just before legislators left Capitol Hill for their Independence Day holiday. Medicare physicians now face 10.6% fee cuts, but there is an opportunity for retrospective increases after the recess.
Read More
Human factors make or break continuous glucose monitoring
June 7th 2008Real-time continuous glucose monitoring (CGM) can significantly improve glycemic control, but it will not help all patients. "Real-time CGM will add significantly to glucose management for some people, but not for all," said Irl Hirsch, MD, University of Washington, Seattle. "Human factors make all the difference between success and failure. Some patients will never figure it out. That?s why real-time control is so challenging.
Read More
Pharmacologic options for painful diabetic neuropathy reviewed
June 7th 2008Good glycemic control is not sufficient to relieve painful diabetic neuropathy, necessitating investigation of other modalities to achieve analgesic efficacy. Dan Ziegler, MD, German Diabetes Clinic, German Diabetes Center, and professor of internal medicine, Leibniz Institute at the Heinrich Heine University, Düsseldorf, provided an overview of pharmacologic treatments that have been explored for painful diabetic neuropathy and the success achieved with each.
Read More
Reformers seek more comparative effectiveness information to control healthcare spending
June 5th 2008Healthcare reform is a high-profile issue in the presidential election campaign, and drug access has become a central theme in the debate. Both Democratic and Republican candidates have rolled out healthcare reform plans that promise to cover the uninsured while also providing tax breaks and other incentives to help individuals obtain health insurance.
Read More
Prophylactic anticoagulation guidelines developed specifically for patients with cancer
June 2nd 2008Ambulatory patients with cancer who are undergoing chemotherapy should not receive prophylactic anticoagulation to prevent venous thromboembolism, according to new guidelines developed by ASCO. "It's not cost effective and we also do not recommend screening these patients for thrombophilia," said Mark Levine, MD, McMaster University, Hamilton, Ontario, Canada.
Read More
Paroxetine ineffective for insomnia treatment in patients with cancer
June 2nd 2008Physicians treating cancer-related depression with paroxetine should not expect patients' insomnia to also improve, according to a study presented by Oxana G. Palesh, PhD, University of Rochester Cancer Center, NY. "We know that insomnia and depression often occur together frequently in the general population, suggesting that there may be a common mechanism," she said.
Read More
Clinicians too cautious in use of chemotherapy for oldest patients with stage III colon cancer
June 2nd 2008Advanced age should not be a barrier to initiating adjuvant chemotherapy in patients with stage III colon cancer. In an observational study, the oldest patients suffered no more adverse events when treated with adjuvant chemotherapy than did younger patients but were much less likely than their younger counterparts to actually receive adjuvant chemotherapy for their colon cancer, said Katherine L. Khan, MD, professor of medicine at the University of California, Los Angeles.
Read More
Fatigue affects broad range of activities among patients with cancer
June 2nd 2008Cancer-related fatigue significantly interferes with patients' quality of life, and some areas often affected among these patients are not normally included on standard quality-of-life assessments, said Karen M. Mustian, PhD, University of Rochester School of Medicine, NY. More randomized, controlled trials are needed to identify these areas, she said.
Read More
MRI added to mammography identifies most ductal components of invasive breast cancer
June 2nd 2008Magnetic resonance imaging (MRI) is superior to mammography alone in diagnosing intraductal components of invasive breast cancer, allowing more accurate mapping before breast conservation surgery, said Simone Schrading, MD, Department of Radiology, University of Bonn, Germany.
Read More
Aerobic and strength exercise program improves several variables during chemotherapy treatment
June 2nd 2008An individualized exercise program may significantly reduce fatigue, increase strength, and improve psychosocial functioning during cancer treatment, according to results of a small study reported by Maike de Wit, University Clinic Hamburg, Germany.
Read More
Blood assay may detect early lung cancer
June 1st 2008An RNA signature present in blood that is highly accurate for detecting prevalent lung cancer can accurately predict the development of lung cancer within the next 2 years 80% of the time, said Thomas Zander, MD, Department of Internal Medicine and the Center for Integrated Oncology, University Clinic Cologne, Germany. "Early detection of lung cancer is a major need, as most patients present for diagnosis at a late stage when there is no chance for cure," Dr Zander said. Two-year survival after a lung cancer diagnosis is approximately 15%. Early detection may therefore be a promising strategy to improve survival rates.
Read More